FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Equine veterinary journal2020; 53(1); 71-77; doi: 10.1111/evj.13277

Modelling the probability and impact of false-positive serology for Borrelia burgdorferi sensu lato: A case study.

Abstract: Serological screening tests for Lyme borreliosis have poor specificity, with potential for misdiagnosis and unnecessary antimicrobial treatment. Objective: To evaluate the impact of Lyme borreliosis seroprevalence and serologic test characteristics on the probability of obtaining a false-positive result and impact on antimicrobial use. Methods: Cross-sectional serological survey and modelling. Methods: Sera from 303 horses in southern Belgium were analysed by enzyme-linked immunosorbent assay (ELISA). Apparent seroprevalence was derived from serological data and a Bayesian estimate of true seroprevalence was computed. These were a starting point to model the impact of test and population characteristics on the probability of obtaining false-positive results and consequently unnecessary treatments and complications. Results: Apparent and true seroprevalence were 22% (95% CI 18%-27%) and 11% (credible interval with 95% probability 0.6%-21%) respectively. We estimate that two-thirds of positive samples are false positive in southern Belgium, with one in five of tested horses potentially misdiagnosed as infected. Around 5% of antimicrobial use in equine veterinary practice in Belgium may be attributable to treatment of a false-positive result. Conclusions: There was uncertainty regarding the ELISA's sensitivity and specificity. Conclusions: This study highlights the importance of appreciating the poor diagnostic value of ELISA screening for Lyme borreliosis as demonstrated by this case study of seroprevalence in southern Belgium where we demonstrate that a nontrivial number of horses is estimated to receive unwarranted treatment due to poor appreciation of screening test characteristics by practitioners, contributing substantially to unnecessary use of antimicrobials.
© 2020 The Authors. Equine Veterinary Journal published by John Wiley & Sons Ltd on behalf of EVJ Ltd.
Get Full Text
Publication Date: 2020-06-23 PubMed ID: 32385952PubMed Central: PMC7818418DOI: 10.1111/evj.13277Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research analyzes the likelihood and impact of incorrect positive results in serological tests for Lyme borreliosis in horses in Belgium. It indicates that there is a significant possibility of these tests resulting in misdiagnosis, leading to unnecessary treatments and antimicrobial use.

Objective and Methodology

  • The objective of this research was to evaluate the impact of Lyme borreliosis seroprevalence, the occurrence of the disease in a specific population, and the characteristics of the serological tests on the probability of getting a false-positive result, leading to unnecessary applications of antimicrobial treatment.
  • Using a cross-sectional serological survey and modelling, the research investigated sera from 303 horses from southern Belgium using enzyme-linked immunosorbent assay (ELISA), a common laboratory test used for detecting and measuring antibodies in blood.
  • The researchers analyzed the apparent seroprevalence derived from the serological data and computed a Bayesian estimate of true seroprevalence as a starting point for their model.
  • The model was designed to study the impact of test and population characteristics on the likelihood of obtaining false-positive results and consequently unnecessary treatments and complications.

Results

  • The results indicated that both apparent and true seroprevalence were 22% (95% CI 18%-27%) and 11% (credible interval with 95% probability 0.6%-21%) respectively.
  • The research suggested that two-thirds of the positive sample results in southern Belgium were false positives, leading to one in five of the tested horses potentially being misdiagnosed as infected.
  • About 5% of antimicrobial use in Belgian equine veterinary practice was likely a result of treatment based on false-positive findings.

Conclusions

  • Despite the study pointing out that uncertainty exists regarding the ELISA’s sensitivity and specificity, it highlighted the crucial need to recognize the poor diagnostic value of ELISA screening for Lyme borreliosis.
  • Through the case study of seroprevalence in southern Belgium, the research illustrates that a considerable amount of horses likely receive unneeded treatment due to a lack of understanding of screening test characteristics by practitioners.
  • The misguided treatments were contributing substantially to the unnecessary use of antimicrobials in the population, not only raising concerns about possible antibacterial resistance but also about the well-being of horses that receive unneeded treatment.

Cite This Article

APA
Houben RMAC, Meersschaert C, Hendrickx G, Pitel PH, Amory H. (2020). Modelling the probability and impact of false-positive serology for Borrelia burgdorferi sensu lato: A case study. Equine Vet J, 53(1), 71-77. https://doi.org/10.1111/evj.13277

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 53
Issue: 1
Pages: 71-77

Researcher Affiliations

Houben, Rosa M A C
  • Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Meersschaert, Carole
  • Laboratoires Réunis, Junglinster, Luxembourg.
Hendrickx, Guy
  • Avia-GIS, Zoersel, Belgium.
Pitel, Pierre-Hugues
  • LABEO Frank Duncombe, Caen, France.
Amory, Hélène
  • FARAH, Faculty of Veterinary Medicine, Liège University, Liège, Belgium.

MeSH Terms

  • Animals
  • Antibodies, Bacterial
  • Bayes Theorem
  • Belgium / epidemiology
  • Borrelia burgdorferi
  • Borrelia burgdorferi Group
  • Cross-Sectional Studies
  • Enzyme-Linked Immunosorbent Assay / veterinary
  • Horse Diseases / diagnosis
  • Horse Diseases / epidemiology
  • Horses
  • Lyme Disease / diagnosis
  • Lyme Disease / epidemiology
  • Lyme Disease / veterinary
  • Seroepidemiologic Studies

Grant Funding

  • Equine Focus Point Belgium

Conflict of Interest Statement

C. Meersschaert and P. Pitel are employed by commercial laboratories which offer diagnostics. Neither laboratory had influence on the content or the submission of this manuscript.

References

This article includes 27 references
  1. Bartol J. Is Lyme disease overdiagnosed in horses?. Equine Vet J 2013 Sep;45(5):529-30.
    doi: 10.1111/evj.12122pubmed: 23909449google scholar: lookup
  2. Divers TJ, Gardner RB, Madigan JE, Witonsky SG, Bertone JJ, Swinebroad EL, Schutzer SE, Johnson AL. Borrelia burgdorferi Infection and Lyme Disease in North American Horses: A Consensus Statement.. J Vet Intern Med 2018 Mar;32(2):617-632.
    doi: 10.1111/jvim.15042pmc: PMC5866975pubmed: 29469222google scholar: lookup
  3. Rizzoli A, Silaghi C, Obiegala A, Rudolf I, Hubálek Z, Földvári G, Plantard O, Vayssier-Taussat M, Bonnet S, Spitalská E, Kazimírová M. Ixodes ricinus and Its Transmitted Pathogens in Urban and Peri-Urban Areas in Europe: New Hazards and Relevance for Public Health.. Front Public Health 2014;2:251.
    doi: 10.3389/fpubh.2014.00251pmc: PMC4248671pubmed: 25520947google scholar: lookup
  4. Stefanciková A, Adaszek Ł, Pet'ko B, Winiarczyk S, Dudinák V. Serological evidence of Borrelia burgdorferi sensu lato in horses and cattle from Poland and diagnostic problems of Lyme borreliosis.. Ann Agric Environ Med 2008;15(1):37-43.
    pubmed: 18581977
  5. Moyaert H, Decostere A, De Wilde H, Liebisch G, Maes D, Deprez P. Seroprevalence of Borrelia burgdorferi sensu lato in horses in Flanders. Vlaam Diergeneeskd Tijdschr 2006;75:436–8.
  6. Laus F, Veronesi F, Passamonti F, Paggi E, Cerquetella M, Hyatt D, Tesei B, Fioretti DP. Prevalence of tick borne pathogens in horses from Italy.. J Vet Med Sci 2013;75(6):715-20.
    doi: 10.1292/jvms.12-0449pubmed: 23328633google scholar: lookup
  7. Egenvall A, Franzén P, Gunnarsson A, Engvall EO, Vågsholm I, Wikström UB, Artursson K. Cross-sectional study of the seroprevalence to Borrelia burgdorferi sensu lato and granulocytic Ehrlichia spp. and demographic, clinical and tick-exposure factors in Swedish horses.. Prev Vet Med 2001 May 1;49(3-4):191-208.
    doi: 10.1016/S0167-5877(01)00187-8pubmed: 11311953google scholar: lookup
  8. Käsbohrer A, Schönberg A. [Serologic studies of the occurrence of Borrelia burgdorferi in domestic animals in Berlin (West)].. Berl Munch Tierarztl Wochenschr 1990 Nov 1;103(11):374-8.
    pubmed: 2268252
  9. Kiss T, Cadar D, Krupaci AF, Bordeanu A, Brudaşcă GF, Mihalca AD, Mircean V, Gliga L, Dumitrache MO, Spînu M. Serological reactivity to Borrelia burgdorferi sensu lato in dogs and horses from distinct areas in Romania.. Vector Borne Zoonotic Dis 2011 Sep;11(9):1259-62.
    doi: 10.1089/vbz.2010.0254pubmed: 21612524google scholar: lookup
  10. Ebani VV, Bertelloni F, Pinzauti P, Cerri D. Seroprevalence of Leptospira spp. and Borrelia burgdorferi sensu lato in Italian horses.. Ann Agric Environ Med 2012;19(2):237-40.
    pubmed: 22742794
  11. Hansen MG, Christoffersen M, Thuesen LR, Petersen MR, Bojesen AM. Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in Danish horses.. Acta Vet Scand 2010 Jan 18;52(1):3.
    doi: 10.1186/1751-0147-52-3pmc: PMC2818635pubmed: 20082693google scholar: lookup
  12. Divers TJ. Equine Lyme disease. J Equine Vet Sci 2013;33:488–92.
    doi: 10.1016/j.jevs.2013.03.187google scholar: lookup
  13. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis.. Lancet 2012 Feb 4;379(9814):461-73.
    doi: 10.1016/S0140-6736(11)60103-7pubmed: 21903253google scholar: lookup
  14. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O'Connell S, Ornstein K, Strle F, Gray J. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe.. Clin Microbiol Infect 2011 Jan;17(1):69-79.
    doi: 10.1111/j.1469-0691.2010.03175.xpubmed: 20132258google scholar: lookup
  15. Barr BS, Waldridge BM, Morresey PR, Reed SM, Clark C, Belgrave R, Donecker JM, Weigel DJ. Antimicrobial-associated diarrhoea in three equine referral practices.. Equine Vet J 2013 Mar;45(2):154-8.
    doi: 10.1111/j.2042-3306.2012.00595.xpubmed: 22779907google scholar: lookup
  16. Meersschaert C, Cerri S, Houben R, Pitel PH, De Waele V, Hendrickx G. Seroprevalence of Borrelia burgdorferi in horses in the southern part of Belgium: a ‘one health’ driven study. Proc AESA .
  17. Sherer R. PropCIs: various confidence interval methods for proportions. R Package version 0.3‐0. 2018.
  18. Rogan WJ, Gladen B. Estimating prevalence from the results of a screening test.. Am J Epidemiol 1978 Jan;107(1):71-6.
    pubmed: 623091doi: 10.1093/oxfordjournals.aje.a112510google scholar: lookup
  19. Devleesschauwer B, Torgerson P, Charlier J, Levecke B, Praet N, Roelandt S, Smit S, Dorny P, Berkvens D, Speybroeck N. Prevalence: tools for prevalence assessment studies. R package version 0.4.0. 2014.
  20. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019.
  21. nNieuws|Autoriteit Diergeneesmiddelenn. http://www.autoriteitdiergeneesmiddelen.nl/nl/nieuws/176/sda‐brief‐antibioticumgebruik‐bij‐paarden (Accessed: 29th November 2017).
  22. Meerschaert C. Séroprévalence de Borrelia burgdorferi chez les chevaux en Wallonie: un indicateur de la maladie de Lyme?. Master Thesis, Université de Liège; 2016.
  23. Wagner B, Goodman LB, Rollins A, Freer HS. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.. Equine Vet J 2013 Sep;45(5):533-7.
    doi: 10.1111/evj.12033pubmed: 23432019google scholar: lookup
  24. Johnson AL, Divers TJ, Chang YF. Validation of an in-clinic enzyme-linked immunosorbent assay kit for diagnosis of Borrelia burgdorferi infection in horses.. J Vet Diagn Invest 2008 May;20(3):321-4.
    doi: 10.1177/104063870802000309pubmed: 18460618google scholar: lookup
  25. Butler CM, Sloet van Oldruitenborgh‐Oosterbaan M, Werners A, Stout TAE, Nielen M, Jongejan F. Borrelia burgdorferi and Anaplasma phagocytophilum in ticks and their equine hosts: a prospective clinical and diagnostic study of 47 horses following removal of a feeding tick. Pferdeheilkunde 2016;32:335–45.
    doi: 10.21836/PEM20160406google scholar: lookup
  26. European Medicines Agency. European Surveillance of Veterinary Antimicrobial Consumption 2018. ‘Sales of veterinary antimicrobial agents in 30 European countries in 2016’. 2018. (EMA/275982/2018).
  27. Wagner B, Freer H, Rollins A, Erb HN, Lu Z, Gröhn Y. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.. Vet Immunol Immunopathol 2011 Dec 15;144(3-4):374-81.
    doi: 10.1016/j.vetimm.2011.08.005pubmed: 21890217google scholar: lookup

Citations

This article has been cited 1 times.
  1. Mukhametov A, Osadchuk M, Berechikidze I, Pronkin N. Epizootiological aspects of natural nidality of Ixodes tick-borne borreliosis in the Moscow region (Russian Federation). Vet World 2022 Jan;15(1):213-219.
    doi: 10.14202/vetworld.2022.213-219pubmed: 35369590google scholar: lookup
Subscribe to our newsletter
Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.